Characteristics | Total (n = 208) | Dippers (n = 104) | Non-dippers (n = 104) | P-value |
---|---|---|---|---|
Age (years) | 58.2 + 16.7 | 53.5 + 16.9 | 63.0 + 15.0 | <  0.001 |
Male n (%) | 77 (37) | 44 (42.3) | 33 (31.7) | 0.114 |
Body weight (kg) | 65.6Â +Â 13.4 | 67.3Â +Â 14.0 | 63.9Â +Â 12.6 | 0.066 |
BMI (kg/m2)* | 24.6 (21.7, 27.5) | 24.7 (21.8, 27.6) | 24.2 (21.5, 27.2) | 0.523 |
Smoking n (%) | 10 (4.8) | 10 (9.6) | 0 (0) | 0.001 |
Co-morbidities n (%) | ||||
 Diabetes mellitus | 47 (22.6) | 13 (12.5) | 34 (32.7) | < 0.001 |
 Dyslipidemia | 122 (58.7) | 50 (48.1) | 72 (69.2) | 0.002 |
 Obstructive sleep apnea | 15 (7.2) | 8 (7.7) | 7 (6.7) | 0.789 |
 Ischemic stroke | 12 (5.8) | 2 (1.9) | 10 (9.6) | 0.017 |
 Coronary artery disease | 10 (4.8) | 4 (3.8) | 6 (5.8) | 0.517 |
 Heart failure | 1 (0.5) | 1 (1) | 0 (0) | 1.000 |
 Chronic kidney disease | 38 (18.3) | 13 (12.5) | 25 (24) | 0.031 |
Number and type of anti-hypertensive medications n (%) | Â | Â | Â | 0.497 |
 1 | 50 (24) | 24 (23.1) | 26 (25) |  |
 2 | 39 (18.8) | 22 (21.2) | 17 (16.3) |  |
 3 | 33 (15.9) | 15 (14.4) | 18 (17.3) |  |
 4 | 19 (9.1) | 6 (5.8) | 13 (12.5) |  |
 5 | 6 (2.9) | 3 (2.9) | 3 (2.9) |  |
Diuretics | 28 (13.5) | 15 (14.4) | 13 (12.5) | 0.685 |
CCBs | 95 (45.7) | 40 (38.5) | 55 (52.9) | 0.037 |
ACEIs | 34 (16.3) | 18 (17.3) | 16 (15.4) | 0.708 |
ARBs | 66 (31.7) | 30 (28.8) | 36 (34.6) | 0.371 |
Beta blockers | 57 (27.4) | 22 (21.2) | 35 (33.7) | 0.043 |
Peripheral alpha-1 blockers | 27 (13) | 11 (10.6) | 16 (15.4) | 0.302 |
Central acting alpha-2 agonists | 9 (4.3) | 4 (3.8) | 5 (4.8) | 1.000 |
Direct vasodilators | 13 (6.2) | 10 (9.6) | 3 (2.9) | 0.045 |
Laboratory results | ||||
 Hemoglobin (g/L)a | 132 (120, 145) | 134 (125, 148) | 130 (117, 140) | 0.006 |
 Hematocrit (%) | 40.6 + 4.8 | 41.6 + 4.5 | 39.7 + 4.8 | 0.005 |
 RDW (%)a | 13.6 (12.8, 14.6) | 13.4 (12.7, 14.6) | 13.7 (12.9, 14.6) | 0.225 |
 MCV (fl)a | 88.5 (82.2, 91.9) | 87.8 (80.9, 91.0) | 89.1 (84.0, 92.0) | 0.162 |
 NLRa | 1.80 (1.33, 2.44) | 1.79 (1.29, 2.50) | 1.85 (1.42, 2.36) | 0.623 |
 PLRa | 123.25 (97.18, 161.71) | 128.39 (98.91, 166.90) | 120.95 (95.09, 158.13) | 0.353 |
 Fasting plasma glucose (mmol/L)a | 5.5 (5.1, 6.3) | 5.4 (4.9, 5.9) | 5.8 (5.3, 6.4) | < 0.001 |
 HbA1c (%)a | 6.0 (5.6, 6.5) | 6.0 (5.7, 6.4) | 6.0 (5.6, 6.6) | 0.655 |
 Cholesterol (mmol/L) | 4.72 + 0.91 | 4.84 + 0.89 | 4.61 + 0.92 | 0.060 |
 Triglyceride (mmol/L)a | 1.12 (0.88, 1.58) | 1.15 (0.92, 1.71) | 1.11 (0.87, 1.55) | 0.495 |
 HDL-cholesterol (mmol/L) | 1.53 + 0.44 | 1.51 + 0.47 | 1.55 + 0.41 | 0.560 |
 LDL-cholesterol (mmol/L) | 2.61 + 0.84 | 2.72 + 0.86 | 2.50 + 0.80 | 0.054 |
 Uric acid (mmol/L) | 0.35 + 0.10 | 0.36 + 0.11 | 0.33 + 0.10 | 0.128 |
 Abnormal proteinuria n (%) | 55 (26.4) | 20 (19.2) | 35 (33.7) | 0.346 |
 Serum creatinine (μmol/L)a | 76.02 (64.53, 97.24) | 76.02 (63.65, 94.59) | 76.02 (64.53, 103.43) | 0.583 |
 eGFR (ml/min/1.73 m2) | 80.22 + 24.25 | 84.69 + 22.98 | 75.75 + 24.76 | 0.008 |